Quality and Regulatory

News Brief: EMA and FDA Unite on AI Principles to Revolutionize Medicine Development

Justin Johnson, PDA

Quality & Regulatory
Ensuring Data Integrity in Pharmaceutical Microbiology Laboratories

Miriam Guest, Charles River Laboratories

Understanding FDA Complete Response Letters

Justin Johnson, PDA

Building Maturity and Resilience Through Quality Culture

Annette Boland, PharmaLex

From Warp Speed to Uncertainty: U.S. Vaccine Policy in Crisis

Anya Hillery, PhD, Freelance Medical Writer

The New Normal at the FDA

Katie Bevard, Eli Lilly

News Brief: FDA Cracks Down on Misleading Drug Ads

Justin Johnson, PDA

FDA Expands Use of Unannounced Foreign Inspections

Louise Uí Fhatharta, Pharmalex

News Brief: FDA Announced FDA Precheck

Justin Johnson, PDA

News Brief: PDA AI Glossary Now Available

Walter Morris, PDA

News Brief: Sean Keveney Appointed Chief Counsel of FDA

Justin Johnson, PDA

News Brief: FDA Releases 200 Drug Rejection Letters

Justin Johnson, PDA

Planning for a Dual-Method Future

Nora Blair, Charles River

Leading the Turnaround

Troy Chavis, PrecisionPharma Manufacturing Solutions, LLC

Effective AI Deployment in Drug Manufacturing

Peter Makowenskyj, MEng, G-CON Manufacturing and Toni Manzano, PhD, Aizon

Leadership, Layoffs, and Legislation

Katie Bevard, Eli Lilly

News Brief: U.S. FDA Launches AI Tool, Elsa

Justin Johnson, PDA

PDA Europe and EMA Unite

Toni Manzano, PhD, Aizon